|
characteristics
|
HPV positive rate in 2612 women
|
HR-HPV rate in CIN group
|
|---|
|
Age
|
|
≤ 29
|
209(80.7%)
|
92(35.5%)
|
|
30–34
|
211(70.1%)
|
106(35.2%)
|
|
35–39
|
182(59.1%)
|
103(33.4%)
|
|
40–44
|
221(49.6%)
|
124(27.8%)
|
|
45–49
|
166(32.0%)
|
89(17.1%)
|
|
50–54
|
149(35.6%)
|
76(18.2%)
|
|
55–59
|
54(41.2%)
|
27(20.6%)
|
|
60–64
|
54(45.0%)
|
32(26.7%)
|
|
65–69
|
27(55.1%)
|
19(38.8%)
|
|
≥ 70
|
23(37.7%)
|
19(31.1%)
|
|
HPV
|
|
Single-type infection
|
950(73.3%)
| |
|
Multiple-type infection
|
346(26.70%)
| |
|
2 types
|
252(72.80%)
| |
|
3 types
|
68(19.70%)
| |
|
4 types
|
19(5.50%)
| |
|
5 types
|
5(1.40%)
| |
|
6 types
|
2(0.60%)
| |
|
HR-multiple
|
218(63.00%)
| |
|
LR-multiple
|
8(2.30%)
| |
|
HR-LR multiple
|
120(34.70%)
| |
- CIN, cervical intraepithelial neoplasia. HR-multiple, multiple high-risk human papillomavirus. LR-multiple, multiple low-risk human papillomavirus. HR-LR multiple, multiple high-risk combined with low risk human papillomavirus
